MetLife Investment Management’s Cytokinetics CYTK Stock Holding History

MetLife Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.13M	Buy	123,329 +1,419	+1%	+$90.2K	0.04%	425
2025 Q4	$7.75M	Sell	121,910 -5,680	-4%	-$353K	0.04%	444
2025 Q3	$7.01M	Sell	127,590 -4,364	-3%	-$180K	0.03%	482
2025 Q2	$4.36M	Buy	131,954 +1,932	+1%	+$67.2K	0.03%	635
2025 Q1	$5.23M	Sell	130,022 -3,680	-3%	-$169K	0.03%	588
2024 Q4	$6.29M	Buy	133,702 +10,394	+8%	+$540K	0.03%	440
2024 Q3	$6.51M	Buy	123,308 +538	+0.4%	+$30K	0.04%	399
2024 Q2	$6.65M	Buy	122,770 +22,222	+22%	+$1.34M	0.04%	361
2024 Q1	$7.05M	Buy	100,548 +51,460	+105%	+$3.98M	0.05%	336
2023 Q4	$4.1M	Hold	49,088	–	–	0.03%	593
2023 Q3	$1.45M	Hold	49,088	–	–	0.01%	1048
2023 Q2	$1.6M	Buy	49,088 +6,111	+14%	+$226K	0.01%	1026
2023 Q1	$1.51M	Hold	42,977	–	–	0.01%	1013
2022 Q4	$1.97M	Hold	42,977	–	–	0.01%	906
2022 Q3	$2.08M	Buy	42,977 +333	+0.8%	+$16K	0.02%	857
2022 Q2	$1.68M	Buy	42,644 +52	+0.1%	+$2.09K	0.01%	961
2022 Q1	$1.57M	Buy	42,592 +13,764	+48%	+$489K	0.01%	1094
2021 Q4	$1.31M	Hold	28,828	–	–	0.01%	1019
2021 Q3	$1.03M	Buy	28,828 +3,351	+13%	+$98.7K	0.01%	1107
2021 Q2	$504K	Hold	25,477	–	–	﹤0.01%	1563
2021 Q1	$593K	Sell	25,477 -2,978	-10%	-$63.6K	0.01%	1426
2020 Q4	$591K	Hold	28,455	–	–	0.01%	1401
2020 Q3	$616K	Buy	28,455 +2,107	+8%	+$49.3K	0.01%	1261
2020 Q2	$621K	Hold	26,348	–	–	0.01%	1260
2020 Q1	$311K	Hold	26,348	–	–	﹤0.01%	1465
2019 Q4	$280K	Hold	26,348	–	–	﹤0.01%	1794
2019 Q3	$300K	Hold	26,348	–	–	﹤0.01%	1708
2019 Q2	$296K	Buy	26,348 +7,632	+41%	+$73.6K	﹤0.01%	1794
2019 Q1	$151K	Hold	18,716	–	–	﹤0.01%	2132
2018 Q4	$118K	Hold	18,716	–	–	﹤0.01%	2213
2018 Q3	$184K	Hold	18,716	–	–	﹤0.01%	2135
2018 Q2	$155K	Hold	18,716	–	–	﹤0.01%	2032
2018 Q1	$135K	Hold	18,716	–	–	﹤0.01%	2084
2017 Q4	$153K	Buy	+18,716	New	+$212K	﹤0.01%	2058